Horan Capital Advisors’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-66
Closed -$1K 87
2020
Q3
$1K Buy
+66
New +$1.15K ﹤0.01% 290
2020
Q1
Sell
-66
Closed -$1K 73
2019
Q4
$1K Hold
66
﹤0.01% 259
2019
Q3
$2K Buy
+66
New +$1.5K ﹤0.01% 264
2019
Q2
Sell
-66
Closed -$1K 74
2019
Q1
$1K Buy
+66
New +$1.16K ﹤0.01% 255
2017
Q4
Sell
-93
Closed -$8K 69
2017
Q3
$8K Buy
+93
New +$6.59K ﹤0.01% 267
2017
Q2
Sell
-4,661
Closed -$339K 75
2017
Q1
$339K Sell
4,661
-61
-1% -$4.01K 0.24% 51
2016
Q4
$277K Buy
+4,722
New +$249K 0.21% 56

Other funds holding ADNT

Horan Capital Advisors's ADNT Position: Q4 2020 in Review

Horan Capital Advisors sold out of Adient (ADNT) in Q4 2020, closing a stake of 66 shares — an estimated $1K sold.

Horan Capital Advisors first reported a position in ADNT in Q4 2016 and held it in 7 quarters. The position peaked at $339K in Q1 2017. 300 funds tracked by Wall St. Rank hold ADNT as of Q4 2020.

  • Horan Capital Advisors reported no remaining Adient position as of Q4 2020 after selling out during the quarter.
  • Horan Capital Advisors sold 66 Adient shares in Q4 2020, an estimated $1K.
  • Horan Capital Advisors first reported a position in Adient in Q4 2016 and held it in 7 quarters.
  • Horan Capital Advisors's Adient position peaked at $339K in Q1 2017.
  • 300 funds tracked by Wall St. Rank held Adient as of Q4 2020.

Based on Horan Capital Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.